Potential Recommendations on Medicaid Outpatient Drug Rebates

Download Publication (pdf)

December 2017

This presentation considered three potential changes that the Commission could recommend to strengthen Medicaid’s drug rebate program:

  • correcting the line extension drug formula,
  • excluding authorized generics from the average manufacturer price of the brand drug, and
  • strengthening federal oversight.

Discussion focused on the merits of these recommendations and their effects on state and federal budgets, drug manufacturers, and beneficiaries.

Publication Type: Presentations

From: December 2017 MACPAC Public Meeting

Tags: prescription drugs, spending, spending growth